201 related articles for article (PubMed ID: 33128383)
1. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
3. Conditioned medium of the osteosarcoma cell line U2OS induces hBMSCs to exhibit characteristics of carcinoma-associated fibroblasts via activation of IL-6/STAT3 signalling.
Lin L; Huang K; Guo W; Zhou C; Wang G; Zhao Q
J Biochem; 2020 Sep; 168(3):265-271. PubMed ID: 32302384
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
5. Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro.
Xu H; Zhang X; Shi Y; Yu K; Jiang Y
Bioengineered; 2022 Mar; 13(3):5653-5662. PubMed ID: 35263202
[TBL] [Abstract][Full Text] [Related]
6. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
7. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway].
Yu X; Wan QL; Li Z; Li ZB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985
[No Abstract] [Full Text] [Related]
8. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
[TBL] [Abstract][Full Text] [Related]
9. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer.
Wan M; Yu H; Zhai H
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38565774
[TBL] [Abstract][Full Text] [Related]
10. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing.
Yu X; Li Z; Wan Q; Cheng X; Zhang J; Pathak JL; Li Z
Biol Chem; 2018 Oct; 399(11):1313-1323. PubMed ID: 30044759
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Sparganii Rhizoma-Curcumae Rhizoma-medicated serum on proliferation, apoptosis, and migration of human ectopic endometrial stromal cells: based on JAK2/STAT3 signaling pathway].
Wang Y; Nie XB; Jin X; Wang JP; Liu LH; Liu J
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3199-3206. PubMed ID: 37382003
[TBL] [Abstract][Full Text] [Related]
13. Notoginsenoside R1 up-regulates microRNA-132 to protect human lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury.
Cong S; Xiang L; Yuan X; Bai D; Zhang X
Int Immunopharmacol; 2019 Mar; 68():137-144. PubMed ID: 30622031
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan from Fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy.
Zhang J; Sun Z; Lin N; Lu W; Huang X; Weng J; Sun S; Zhang C; Yang Q; Zhou G; Guo H; Chi J
Biomed Pharmacother; 2020 Oct; 130():110534. PubMed ID: 32711244
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC
Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163
[TBL] [Abstract][Full Text] [Related]
16. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
[No Abstract] [Full Text] [Related]
17. Bisphenol A interacts with DLGAP5 and regulates IL-6/JAK2/STAT3 signaling pathway to promote tumorigenesis and progression of osteosarcoma.
Wang Y; Kang J; Wang R; Ramezani K; Bonakdar M; Moghimi N; Salimi M; Yao Y; Wang K
Chemosphere; 2023 Jan; 312(Pt 1):136545. PubMed ID: 36155021
[TBL] [Abstract][Full Text] [Related]
18. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Liang JR; Yang H
Biomed Pharmacother; 2020 May; 125():109585. PubMed ID: 32106377
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
Lee CY; Hsieh SL; Hsieh S; Tsai CC; Hsieh LC; Kuo YH; Wu CC
Oncol Rep; 2017 Jan; 37(1):399-407. PubMed ID: 27840961
[TBL] [Abstract][Full Text] [Related]
20. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
